"Separating contenders from
pretenders in breast cancer"

-- ASCO Post

"Blazes a trail in breast cancer"

-- Nature Biotechnology

"A glimpse into the future of
phase II drug development?"

-- NEJM

I-SPY Email List Sign-up

!!! Important COVID-19 Information for I-SPY2 Consortium Members !!!

Click here for COVID-19 Information for I-SPY2 Participants

Featured News

QLHC Announces Selection of Sanofi's SAR439859 as oral SERD Backbone Agent in Endocrine Optimization Pilot Study QLHC Announces Selection of Sanofi's SAR439859 as oral SERD Backbone Agent in Endocrine Optimization Pilot Study

Press Release

June 8, 2020

Quantum Leap Healthcare’s I-SPY 2 Investigators, ARDS Experts and COVID R&D Consortium Unite to Bring Success from the I-SPY Adaptive Platform Clinical Trial to COVID-19 ARDS ICU Patients Quantum Leap Healthcare’s I-SPY 2 Investigators, ARDS Experts and COVID R&D Consortium Unite to Bring Success from the I-SPY Adaptive Platform Clinical Trial to COVID-19 ARDS ICU Patients

Press Release

April 28, 2020

Quantum Leap Healthcare Collaborative and G1 Therapeutics Announce the Selection of Trilaciclib in the I-SPY 2 TRIAL for Breast Cancer Quantum Leap Healthcare Collaborative and G1 Therapeutics Announce the Selection of Trilaciclib in the I-SPY 2 TRIAL for Breast Cancer

Press Release

January 14, 2020

-- more news --

What is I-SPY?

The I-SPY series of trials are changing the way new treatments are developed for breast cancer, helping make available new, better and more personalized treatments, faster. At the heart of the I-SPY program is the ground-breaking I-SPY 2 platform trial for neoadjuvant treatment of locally advanced breast cancer.

1400

patients enrolled

16

agents completed
evaluation since 2010

3

agents received
accelerated approval

World-class science requires world-class scientists

Meet some of our team

Assistant Professor of Medicine

NewYork-Presbyterian Hospital/Columbia University Medical Center

Associate Professor of Surgery

University of Southern California

Director, Carol Franc Buck Breast Care Center

University of California, San Francisco

Breast Cancer Advocate

Biomarkers, UCSF Breast Science Advocacy

Don't miss a thing! Get I-SPY results, news and event information delivered right to your inbox.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

I-SPY is supported by:

I-SPY Sponsor:
‍

Quantum Leap Healthcare Collaborative